ERC Starting Grant · 2025
Metastasis research is one of the greatest challenges in the medical field. The nanoengineering of inorganic/organic nanoparticles (NPs) with natural signaling carriers such as extracellular vesicles (EVs) is a promising tool to address the lack of treatment efficiency of currently available therapies, blamed on the insufficient accumulation of the antitumoral molecules in the metastasis tissues. Despite several years of intense efforts, therapeutic EVs are still far away from clinical practice. Recent studies have evidenced that this failure is due to the lack of knowledge on how EVs behave in biological environments and how their therapeutic cargo affects the metastasis targeting moieties…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.